| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |